原发性肾病综合征患者74例的临床治疗分析

摘要

目的 分析原发性肾病综合症患者的疗效.方法 选择我院2013年1月~2014年1月收治的肾病综合症患者74例,随机分为对照组与研究组,各37例,给予对照组常规治疗,研究组采用霉酚酸酯治疗,观察两组治疗后的疗效、不良反应以及肾功能变化情况.结果 经治疗后,研究组患者的尿蛋白以及血清蛋白定量变化明显优于对照组,且研究组患者的总有效率明显优于对照组,两组比较差异具有统计学意义(P<0.05).结论 给予肾病综合征患者霉酚酸酯疗效较为确切,能够有效改善患者的尿蛋白以及血清蛋白功能,抑制不良反应发生率,值得在临床中推广和应用.%Objective To observe clinical therapeutic effect of primary nephrotic syndrome patients. Methods From January 2013 to January 2014 were treated 74 cases of patients with nephrotic syndrome, were randomly divided into control group and the team all 37 cases, give control group routine treatment, the team with mycophenolate mofetil treatment, observe the treatment effect of the two groups after treatment, adverse reactions, and renal function changes.Results After treatment, the research group of patients with urinary protein and serum protein quantitative change was better than control group, and group total effective rate of the patients was better than control group, two groups are significant difference, statistically significant (P<0.05).Conclusion For nephrotic syndrome patients more exactly, the effect of mycophenolate mofetil treatment can effectively improve the patient's urine protein and serum protein function, inhibit the incidence of adverse reactions, worthy of popularization and application in clinical.